Petition for a PAUSE to NICE and NHS England decision to introduce QALYS into the appraisal of highly specialised technologies affecting reimbursement of drugs for ultra-rare diseases in England
NICE and NHS England’s decision puts patient access to ultra-rare disease medicine at serious risk. This change to the arrangements… read more
